Current Members



Forest White

Forest White

Ned C. (1949) and Janet C. (Bemis) Rice Professor of Biological Engineering
Ph.D., Florida State University (1997)
B.S., Framingham State College (1993)

Forest is a professor of biological engineering at MIT, a member of the Koch Institute, and a member of the MIT Center for Precision Cancer Medicine. He earned his bachelor's degree in Chemistry from Framingham State College, and a doctorate in Analytical Chemistry from Florida State University. Following postdoctoral research with Donald Hunt at the University of Virginia, he joined MDS Proteomics, Inc. as a research scientist working his way up to group leader. Forest joined MIT as an assistant professor in 2003, where he has received several awards including the Mitsui Career Deveopment Professorship (2005-2008) and the Ruth and Joel Spira Award for Excellence in Teaching in 2010.


Graduate students


Hannah Boyce

Ph.D. Candidate, Chemical Engineering
B.S., Northeastern University (2023)

Hannah is a lifelong Massachusetts resident and earned her B.S. in Chemical Engineering from Northeastern University, where she did co-ops focused on drug delivery in industry, at Brigham and Women's Hospital, and at ETH Zurich in Switzerland. At MIT, she is interested in applying chemical engineering principles to understand cellular control and communication through phosphoproteomics. If she's out of lab, she's probably hiking, biking, planning her next camping trip, or cooking with friends.

Elizabeth Choe

Ph.D. Candidate, Biological Engineering
B.S., Massachusetts Institute of Technology (2013)

Elizabeth received her B.S. in Biological Engineering from MIT before spending several years working as a science media producer and educational researcher for MIT Open Learning, the MIT Media Lab's Learning Initiative, National Geographic, NIH, and MIT Undergraduate Admissions. She now uses phosphoproteomics to understand mechanisms of resistance and signatures of treatment in various glioblastoma therapies. Elizabeth enjoys the four M's: movies, memes, music, and Missouri (<-her home state).

Yufei Cui

Ph.D. Candidate, Biological Engineering
B.S., Rice University (2021)

Yufei received her B.S. in bioengineering from Rice University. Now she is exploring the interaction of tumor with immune cells during immunotherapy treatment using immunopeptidomics and phosphoproteomics approaches. Outside of lab, she enjoys playing volleyball, watching anime and exploring restaurants around the city.

Alicia D'Souza

Ph.D. Candidate, Medical Engineering and Medical Physics
B.S., Stanford University (2019)

Originally from Texas, Alicia received her B.S. in Chemical Engineering from Stanford University. At MIT, she is interested in using phosphoproteomics and systems biology to study T cell signaling networks to inform cancer immunotherapy. Outside of lab, she enjoys trying out new restaurants, traveling, and practicing with the MIT Triathlon Club.

Weixi (Vincent) Kang

Ph.D. Student, Biological Engineering
B.A., Vanderbilt University (2023)

Originally from Beijing, China, Weixi received his B.A. in Chemistry and History from Vanderbilt University. At MIT, he is interested in using immunopeptidomics and phosphoproteomics to develop new therapies for untreatable diseases such as pancreatic cancer. Outside of the lab, he enjoys traveling, tennis, and searching for good restaurants around the area.

Cameron Flower

Ph.D. Candidate, Computational and Systems Biology
B.S.E., University of Connecticut (2017)

Cam studied Biomedical Engineering in his home state at UConn, where he became interested in bioinformatics and systems biology. He now uses phosphoproteomics and computational methods to study how cancer cells rapidly respond to and resist targeted therapy. He also works on developing targeted mass spectrometry methods for monitoring cell signaling. Outside the lab, Cam enjoys exploring Cambridge and hiking/skiing the New England slopes.

Do Hun (Sean) Kim

Ph.D. Candidate, Biological Engineering
B.S., Johns Hopkins University (2017)

Sean received his bachelor’s degree in Biomedical Engineering at Johns Hopkins University where he spent most of the time studying cell and tissue engineering. He is now interested in using mass spectrometry and immunopeptidomic methods to study drug response mechanisms in glioblastoma. Outside of lab, he enjoys working out, swimming, and watching movies.

Owen Leddy

Ph.D. Candidate, Biological Engineering
B.S., University of Chicago (2019)

Owen grew up in Los Angeles and studied Biological Chemistry at the University of Chicago. His current research focuses on identifying peptide antigens presented on MHCs by phagocytes infected with Mycobacterium tuberculosis in order to select targets for the development of effective tuberculosis vaccines. Outside of research, his interests include writing fiction, web app development, and climate justice advocacy.


Postdoctoral associates


Ryuhjin Ahn

Ph.D., McGill University (2019)
B.Sc., McGill University (2011)

Ryuhjin's research focuses on understanding the various aspects of tumor-host interaction at the level of signal transduction using proteomics, animal models, and molecular biology approaches.

Bokai Song

Ph.D., Princeton University (2022)
B.Sc., Tsinghua University (2015)

Bokai Song received his Bachelor of Science degree in Biological Sciences (why so many B.S.) at Tsinghua University in Beijing, close to his hometown Tianjin, China.  He then came to the U.S. and got his Ph.D. in Ileana Cristea’s lab at Princeton University, where he applied proteomics to studying host innate immune response against viral infection. He is now a fan of PTMs and neoantigens in the White Lab, hoping to define potential therapeutic targets and mechanisms of resistance to existing therapies by analyzing clinical human tumor specimens.

Tigist Tamir

Ph.D., University of North Carolina at Chapel Hill (2019)
B.S., The College of William & Mary (2012)

Originally from Ethiopia, Tigist has lived in Virginia and North Carolina since moving to the United States. She received her B.S. in Biology and Bio-Mathematics from the College of William and Mary, and her Ph.D. in Pharmacology from the University of North Carolina at Chapel Hill. Her scientific focus is on identifying the convergence between cancer cell signaling and metabolism. She is applying techniques in proteomics, metabolomics, and computational modeling to study the processes that promote resistance to cancer therapy. Outside of the lab, Tigist enjoys traveling, dancing, martial arts, and the outdoors.



Last updated: 2024-2-28